Search alternatives:
migration algorithm » generation algorithm (Expand Search), location algorithm (Expand Search), maximization algorithm (Expand Search)
multiple solid » multiple sobel (Expand Search)
Showing 1 - 12 results of 12 for search 'multiple solid ((migration algorithm) OR (encryption algorithm))', query time: 0.29s Refine Results
  1. 1
    Image_1_OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.tif

    Image_1_OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.tif by Jiaxing Lin (1581886)

    Published 2021
    Save to List
    Saved in:
  2. 2
    Table_1_OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.xlsx

    Table_1_OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts.xlsx by Jiaxing Lin (1581886)

    Published 2021
    Save to List
    Saved in:
  3. 3
    Image_2_CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway.jpeg

    Image_2_CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway.jpeg by Mingyuan Tao (5745131)

    Published 2023
    Save to List
    Saved in:
  4. 4
    Image_1_CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway.jpeg

    Image_1_CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway.jpeg by Mingyuan Tao (5745131)

    Published 2023
    Save to List
    Saved in:
  5. 5
    Table_1_CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway.xlsx

    Table_1_CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway.xlsx by Mingyuan Tao (5745131)

    Published 2023
    Save to List
    Saved in:
  6. 6
    Image_3_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.tif

    Image_3_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.tif by Chong Shen (173768)

    Published 2022
    Save to List
    Saved in:
  7. 7
    DataSheet_1_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.zip

    DataSheet_1_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.zip by Chong Shen (173768)

    Published 2022
    Save to List
    Saved in:
  8. 8
    Table_1_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.docx

    Table_1_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.docx by Chong Shen (173768)

    Published 2022
    Save to List
    Saved in:
  9. 9
    Image_2_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.tif

    Image_2_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.tif by Chong Shen (173768)

    Published 2022
    Save to List
    Saved in:
  10. 10
    Table_2_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.docx

    Table_2_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.docx by Chong Shen (173768)

    Published 2022
    Save to List
    Saved in:
  11. 11
    Image_1_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.tif

    Image_1_Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer.tif by Chong Shen (173768)

    Published 2022
    Save to List
    Saved in:
  12. 12
    DataSheet_1_Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.docx

    DataSheet_1_Integration of multi-omics and clinical treatment data reveals bladder cancer therapeutic vulnerability gene combinations and prognostic risks.docx by Yan Xu (14594)

    Published 2024
    “…</p>Results<p>PMRI, which consists of four anti-PD-L1 immunotherapy-associated genes (IGF2BP3, P4HB, RAC3, and CLK2), is a reliable predictor of survival in patients with BCa and has been validated using multiple external datasets. We found higher levels of immune cell infiltration and better responses to immunotherapy and cisplatin chemotherapy in the high PMRI group than in the low PMRI group, which can also be used to predict immune efficacy in a variety of solid tumors other than BCa. …”
    Save to List
    Saved in:

Search Tools: